VTVT Valuation

vTv Therapeutics Inc

Add to Watchlist

Advanced Chart

15.140

-0.51(-3.259%)1D

Overview
Forecast
Valuation
Earnings

VTVT Relative Valuation

VTVT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VTVT is overvalued; if below, it's undervalued.

Historical Valuation

vTv Therapeutics Inc (VTVT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.18. The fair price of vTv Therapeutics Inc (VTVT) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：15.36

Fair

-3.83

Trailing

Forward

0.00

EV/EBITDA

vTv Therapeutics Inc. (VTVT) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.25. The thresholds are as follows: Strongly Undervalued below -1.77, Undervalued between -1.77 and -0.76, Fairly Valued between 1.27 and -0.76, Overvalued between 1.27 and 2.28, and Strongly Overvalued above 2.28. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-2.32

EV/EBIT

vTv Therapeutics Inc. (VTVT) has a current EV/EBIT of -2.32. The 5-year average EV/EBIT is -2.73. The thresholds are as follows: Strongly Undervalued below -8.70, Undervalued between -8.70 and -5.72, Fairly Valued between 0.25 and -5.72, Overvalued between 0.25 and 3.24, and Strongly Overvalued above 3.24. The current Forward EV/EBIT of -2.32 falls within the Historic Trend Line -Fairly Valued range.

0.00

vTv Therapeutics Inc. (VTVT) has a current PS of 0.00. The 5-year average PS is 30.86. The thresholds are as follows: Strongly Undervalued below -51.84, Undervalued between -51.84 and -10.49, Fairly Valued between 72.22 and -10.49, Overvalued between 72.22 and 113.57, and Strongly Overvalued above 113.57. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-4.04

P/OCF

vTv Therapeutics Inc. (VTVT) has a current P/OCF of -4.04. The 5-year average P/OCF is -9.85. The thresholds are as follows: Strongly Undervalued below -77.83, Undervalued between -77.83 and -43.84, Fairly Valued between 24.14 and -43.84, Overvalued between 24.14 and 58.13, and Strongly Overvalued above 58.13. The current Forward P/OCF of -4.04 falls within the Historic Trend Line -Fairly Valued range.

-3.82

P/FCF

vTv Therapeutics Inc. (VTVT) has a current P/FCF of -3.82. The 5-year average P/FCF is -0.71. The thresholds are as follows: Strongly Undervalued below -3.21, Undervalued between -3.21 and -1.96, Fairly Valued between 0.55 and -1.96, Overvalued between 0.55 and 1.80, and Strongly Overvalued above 1.80. The current Forward P/FCF of -3.82 falls within the Strongly Undervalued range.

vTv Therapeutics Inc (VTVT) has a current Price-to-Book (P/B) ratio of 14.83. Compared to its 3-year average P/B ratio of 0.48 , the current P/B ratio is approximately 2963.64% higher. Relative to its 5-year average P/B ratio of -1.19, the current P/B ratio is about -1345.04% higher. vTv Therapeutics Inc (VTVT) has a Forward Free Cash Flow (FCF) yield of approximately -20.59%. Compared to its 3-year average FCF yield of -47.17%, the current FCF yield is approximately -56.36% lower. Relative to its 5-year average FCF yield of -36.91% , the current FCF yield is about -44.23% lower.

14.40

P/B

Median3y

0.48

Median5y

-1.19

-20.59

FCF Yield

Median3y

-47.17

Median5y

-36.91

Competitors Valuation Multiple

The average P/S ratio for VTVT's competitors is 13.04, providing a benchmark for relative valuation. vTv Therapeutics Inc Corp (VTVT) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Verrica Pharmaceuticals Inc

Jupiter Neurosciences Inc

76.71

51.20M

CPIX.O

Cumberland Pharmaceuticals Inc

Performance Decomposition

Market capitalization of VTVT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of VTVT in the past 1 year is driven by Unknown.